DE69918165D1 - Doramectinformulierungen - Google Patents

Doramectinformulierungen

Info

Publication number
DE69918165D1
DE69918165D1 DE69918165T DE69918165T DE69918165D1 DE 69918165 D1 DE69918165 D1 DE 69918165D1 DE 69918165 T DE69918165 T DE 69918165T DE 69918165 T DE69918165 T DE 69918165T DE 69918165 D1 DE69918165 D1 DE 69918165D1
Authority
DE
Germany
Prior art keywords
doramectinformulierungen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69918165T
Other languages
English (en)
Other versions
DE69918165T2 (de
Inventor
Denise Harding
Richard Wicks
Michael Lukas
Snezana Milojevic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of DE69918165D1 publication Critical patent/DE69918165D1/de
Application granted granted Critical
Publication of DE69918165T2 publication Critical patent/DE69918165T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69918165T 1998-12-16 1999-11-22 Doramectinformulierungen Expired - Lifetime DE69918165T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9827727.0A GB9827727D0 (en) 1998-12-16 1998-12-16 Antiparasitic formulations
GB9827727 1998-12-16
PCT/IB1999/001854 WO2000035445A1 (en) 1998-12-16 1999-11-22 Doramectin formulations

Publications (2)

Publication Number Publication Date
DE69918165D1 true DE69918165D1 (de) 2004-07-22
DE69918165T2 DE69918165T2 (de) 2004-10-14

Family

ID=10844352

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69918165T Expired - Lifetime DE69918165T2 (de) 1998-12-16 1999-11-22 Doramectinformulierungen

Country Status (21)

Country Link
US (1) US6699847B2 (de)
EP (1) EP1140068B1 (de)
JP (1) JP3848537B2 (de)
AP (1) AP9901699A0 (de)
AR (1) AR019499A1 (de)
AT (1) ATE269074T1 (de)
AU (1) AU762892B2 (de)
BR (1) BR9916265A (de)
CA (1) CA2355102C (de)
DE (1) DE69918165T2 (de)
DK (1) DK1140068T3 (de)
ES (1) ES2221455T3 (de)
GB (1) GB9827727D0 (de)
GT (1) GT199900213A (de)
MA (1) MA26710A1 (de)
PA (1) PA8486601A1 (de)
PE (1) PE20001244A1 (de)
PT (1) PT1140068E (de)
TN (1) TNSN99225A1 (de)
TW (1) TW524691B (de)
WO (1) WO2000035445A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003257778A1 (en) * 2002-08-02 2004-02-23 Shenzhen Salubris Pharmaceuticals Co., Ltd. A riboflavin derivative and its manufacture and uses
AU2003235019A1 (en) * 2003-08-17 2005-03-03 Sirene Call Pty Ltd Attract-and-Kill Method of Controlling Ecto-Parasites from the Order Acarina in Livestock and Domestic Animals as well as Members of the Order Artiodactyle
AU2009271299B2 (en) * 2008-06-24 2014-09-11 Boehringer Ingelheim Animal Health USA Inc. Anthelminthic formulations
MX2009001235A (es) * 2008-09-19 2010-04-29 Agrovet Market S A Composicion y uso de un gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina.
WO2010116267A1 (en) 2009-02-16 2010-10-14 Pfizer Inc. High dosage doramectin formulation
CN103417477B (zh) * 2012-05-18 2015-08-05 中国农业科学院兰州畜牧与兽药研究所 一种以水为基质的多拉菌素o/w型注射液及其制备方法
CN104822299B (zh) 2012-11-09 2018-11-20 伊莱克斯公司 拌合器
EA037747B1 (ru) * 2019-04-01 2021-05-18 Севиндж Аллахверди кызы АЛИЕВА Антипаразитарное средство

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL151903B (nl) 1965-03-24 1977-01-17 Schering Ag Werkwijze ter bereiding van een injectievloeistof door een steroid op te lossen in een mengsel van ricinusolie en benzylbenzoaat.
DE3377064D1 (en) 1982-12-28 1988-07-21 Bayer Ag Stable aminoglycoside-penicillin injection formulation
DE3484584D1 (de) 1983-10-14 1991-06-20 Sumitomo Pharma Injektionen mit verzoegerter abgabe.
ZA866218B (en) 1985-08-23 1988-03-30 Lilly Co Eli Injectable sustained release formulation
ES2052173T3 (es) 1989-04-11 1994-07-01 Pfizer Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.
NZ234802A (en) 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
ATE180671T1 (de) 1991-09-30 1999-06-15 Merck & Co Inc Hydrierte rizinusöl-enthaltende injizierbare formulierungen mit verlängerter wirkstoffabgabe
DE4410970C1 (de) 1994-03-29 1995-07-20 Talbot Waggonfab Wankstütze für Schienenfahrzeuge mit einer Querneigeeinrichtung
US5580574A (en) 1994-04-28 1996-12-03 Hoffmann-La Roche Inc. Pharmaceutical composition for transdermal delivery
US6013636A (en) * 1995-09-25 2000-01-11 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil

Also Published As

Publication number Publication date
EP1140068A1 (de) 2001-10-10
DK1140068T3 (da) 2004-07-12
ATE269074T1 (de) 2004-07-15
JP2002532422A (ja) 2002-10-02
PE20001244A1 (es) 2000-11-07
GT199900213A (es) 2001-06-07
AU762892B2 (en) 2003-07-10
AU1069900A (en) 2000-07-03
MA26710A1 (fr) 2004-12-20
PT1140068E (pt) 2004-09-30
JP3848537B2 (ja) 2006-11-22
BR9916265A (pt) 2001-11-20
ES2221455T3 (es) 2004-12-16
CA2355102C (en) 2006-07-11
AP9901699A0 (en) 2001-05-22
US20020142972A1 (en) 2002-10-03
WO2000035445A1 (en) 2000-06-22
GB9827727D0 (en) 1999-02-10
EP1140068B1 (de) 2004-06-16
PA8486601A1 (es) 2000-09-29
CA2355102A1 (en) 2000-06-22
DE69918165T2 (de) 2004-10-14
TNSN99225A1 (fr) 2005-11-10
US6699847B2 (en) 2004-03-02
AR019499A1 (es) 2002-02-20
TW524691B (en) 2003-03-21

Similar Documents

Publication Publication Date Title
DE69936443D1 (de) Bedienungspersoneingagabevorrichtung
DE69924816D1 (de) Fluidumverdichter
DE69940913D1 (de) Ldautomat
DE69909757D1 (de) Ethylencopolymerisationsverfahren
DE69919740D1 (de) Radialreifenwulst
DE69904565D1 (de) Hubventilsteuerungseinrichtung
DE69924838D1 (de) Einlasslufterhitzmodule
DE69936094D1 (de) Banknotenabtaster
DE59907306D1 (de) Fadenchangierung
DE69926033D1 (de) Schlüsselkodekorrelationsanordnung
DE69907576D1 (de) Solenoidantriebsvorrichtung
DE69940418D1 (de) Tonsignalsmischung
DE69939251D1 (de) Funkpeilsystem
FI980472A0 (fi) Laddningsfoerfarande och -arrangemang
DE59908968D1 (de) Benzoylpyridazine
FI980076A0 (fi) Cellulaerradiosystem
DE69827358D1 (de) Weglenkungsverfahren
DE69906909D1 (de) Gerotormotor
DE69935824D1 (de) Münzschiebespielgerät
DE69941418D1 (de) Ziehvverfahren
DE69902306D1 (de) Schwellwertventil
DE69918165D1 (de) Doramectinformulierungen
DE69935559D1 (de) Bussignalleitungstreiber
DE59912033D1 (de) Herz-Lungen-Maschine
DE69930581D1 (de) Bremskaftverstärker

Legal Events

Date Code Title Description
8364 No opposition during term of opposition